Degree and duration of reversal by naloxone of effects of morphine in conscious subjects
- PMID: 4833964
- PMCID: PMC1610781
- DOI: 10.1136/bmj.2.5919.589
Degree and duration of reversal by naloxone of effects of morphine in conscious subjects
Abstract
The effects of intravenous naloxone on several of the actions of intravenous morphine (mean dose 30 mg/70 kg) were studied in six volunteer subjects. Naloxone produced a well defined reversal of the respiratory depression, analgesia, and miotic and subjective effects of the morphine. The agonist action of morphine outlasted the antagonist action of a single dose of naloxone. The effect of repeated doses of naloxone was also short-lived, but continuous infusions were effective in maintaining reversal.
Similar articles
-
Potency, duration of action and pA2 in man of intravenous naloxone measured by reversal of morphine-depressed respiration.J Pharmacol Exp Ther. 1981 Oct;219(1):156-62. J Pharmacol Exp Ther. 1981. PMID: 7288605 Clinical Trial.
-
Failure of nalbuphine to antagonize morphine: a double-blind comparison with naloxone.Anesth Analg. 1986 Jun;65(6):605-11. Anesth Analg. 1986. PMID: 3085551 Clinical Trial.
-
Reversal of morphine anesthesia with naloxone.Anesthesiology. 1974 Oct;41(4):361-7. doi: 10.1097/00000542-197410000-00010. Anesthesiology. 1974. PMID: 4415623 No abstract available.
-
Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.J Pharmacol Exp Ther. 1989 Jan;248(1):127-34. J Pharmacol Exp Ther. 1989. PMID: 2913267
-
Naloxone reversal of buprenorphine-induced respiratory depression.Clin Pharmacol Ther. 1989 Jan;45(1):66-71. doi: 10.1038/clpt.1989.10. Clin Pharmacol Ther. 1989. PMID: 2491980 Clinical Trial.
Cited by
-
Effects of naloxone on pethidine-induced neonatal depression. Part I--Intravenous naloxone.Br Med J. 1977 Jul 23;2(6081):228-9. doi: 10.1136/bmj.2.6081.228. Br Med J. 1977. PMID: 328108 Free PMC article. Clinical Trial.
-
Naloxone dosage for opioid reversal: current evidence and clinical implications.Ther Adv Drug Saf. 2018 Jan;9(1):63-88. doi: 10.1177/2042098617744161. Epub 2017 Dec 13. Ther Adv Drug Saf. 2018. PMID: 29318006 Free PMC article. Review.
-
PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and naloxone antagonism in humans.Acta Pharmacol Sin. 2024 Aug;45(8):1752-1764. doi: 10.1038/s41401-024-01255-2. Epub 2024 Apr 3. Acta Pharmacol Sin. 2024. PMID: 38570601 Free PMC article.
-
Prediction of naloxone dose in opioids toxicity based on machine learning techniques (artificial intelligence).Daru. 2024 Dec;32(2):495-513. doi: 10.1007/s40199-024-00518-x. Epub 2024 May 21. Daru. 2024. PMID: 38771458 Free PMC article.
-
Dihydrocodeine overdose treated with naloxone infusion.Br Med J (Clin Res Ed). 1983 Nov 19;287(6404):1547-8. doi: 10.1136/bmj.287.6404.1547. Br Med J (Clin Res Ed). 1983. PMID: 6416494 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources